TNFRSF11A and breast cancer: Pfitzner et al. analyzed the tissue expression of 601 patients with breast cancer, the disease best studied, and found that high RANK expression was associated with high pathological complete response, shorter disease-free and overall survival, and higher sensitivity to chemotherapy, but also a higher risk of relapse and death [10].